NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Capricor Therapeutics Inc Share Price Chart

O H L

Capricor Therapeutics Inc Performance Overview

Days Range
$9.02Low
$9.35High

Markets Today

Previous Close$9.42
Open$9.31
Volume726,823
Day's Range$9.02 - $9.35
52W Range$2.96 - $40.37
Market Cap$497.67 M

Historical Performance

1M Returns+33.05
3M Returns-66.81
6M Returns-69.51
1Y Returns+47.19
5Y Returns+87.28
10Y Returns-74.88

Capricor Therapeutics Inc Fundamentals

Market Cap$497.67 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.47
EPS TTM$-2.45
Quarterly Earnings Growth YOYN/A
PB Ratio2.02
EBITDA$-106.25 M
Profit MarginN/A
Market Cap$497.67 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.47
EPS TTM$-2.45
Quarterly Earnings Growth YOYN/A
PB Ratio2.02
EBITDA$-106.25 M
Profit MarginN/A

Capricor Therapeutics Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$24.98 M-$27.72 M-$26.28 M-$29.16 M-$36.77 M-$42.95 M
EBITDA -$24.58 M-$27.23 M-$25.79 M-$28.65 M-$36.24 M-$42.38 M
Interest Expense $0$0$0-$3.05 M$0$0
Depreciation $405.45 K$486.28 K$494.73 K$502.59 K$534.67 K$561.85 K
Income Before Tax -$24.39 M-$25.91 M-$24.57 M-$30.17 M-$33.94 M-$40.73 M
Income Tax Expense $0$1.60 K$0$1.60 K$0$1.60 K
Net Income +-$24.39 M-$25.91 M-$24.57 M-$30.17 M-$33.94 M-$40.73 M
Net Profit Margin ------

Capricor Therapeutics Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $45.68 K$45.71 K$45.72 K$57.37 K$57.66 K$58.11 K
Reserve & Surplus -$222.41 M-$248.75 M-$273.86 M-$304.60 M-$339.07 M-$379.72 M
Non-Current Liabilities $3.78 M$194.60 K$14.42 M$14.32 M$13.94 M$89.56 M
Current Liabilities $22.34 M$28.40 M$28.15 M$35.84 M$33.64 M$32.96 M
Total Liabilities $26.12 M$28.59 M$42.57 M$50.16 M$47.58 M$122.52 M
Fixed Assets $6.13 M$8.00 M$11.07 M$18.31 M$28.50 M$36.35 M
Current Assets $146.25 M$124.13 M$100.95 M$322.94 M$283.09 M$242.13 M
Total Assets $153.77 M$133.57 M$126.44 M$355.95 M$326.28 M$368.74 M

Capricor Therapeutics Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$24.39 M-$25.91 M-$24.57 M-$30.17 M-$33.94 M-$40.73 M
Operating Cash Flow -$6.43 M-$20.12 M-$19.69 M-$23.57 M-$29.25 M-$31.49 M
Investing Cash Flow $23.89 M$14.55 M$15.95 M$43.09 M-$154.64 M-$48.76 M
Financing Cash Flow $50.35 K$19.58 K$6.95 K$248.82 M$1.47 M-$4.24 M
Change in Cash $17.51 M-$5.55 M-$3.73 M$268.34 M-$182.43 M-$84.49 M

Capricor Therapeutics Inc Return Calculator

The Capricor Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$17,992
Invested Amount$10,000
Est. Returns$7,992
Invest in USA Stock Today

About Capricor Therapeutics Inc

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

FAQs

Capricor Therapeutics Inc (CAPR) share price as of September 18, 2026 is $9.05. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Capricor Therapeutics Inc (CAPR) Share by opening an international trading account with Angel One.
Purchasing Capricor Therapeutics Inc (CAPR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Capricor Therapeutics Inc (CAPR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Capricor Therapeutics Inc (CAPR) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Capricor Therapeutics Inc on September 18, 2026, is $497.67 M.
Capricor Therapeutics Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Capricor Therapeutics Inc (CAPR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91